stockrow
Friday 6 November 2026
Export PETV’s income statement to Excel — free account
PetVivo Holdings, Inc.
PETV Healthcare Medical Devices
PetVivo Holdings, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 million, up 0.80% from fiscal 2025.
- Revenue
- +13.5%
- EPS
- +44.4%
- Free cash flow
- +40.1%
Quarter to June 2026, against a year earlier
0.63
0.01
+1.61%
Follow PETV
Alert me
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 5 | — | — | — | 5 | 3 | 4 | 4 | 3 |
P/E ratio |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
505.14 | 6,635.64 | — | 509.75 | 5,165.58 | 154.60 | 30.65 | 14.42 | 10.86 | 18.49 |
Altman Z-Score |
(60.69) | (38.37) | — | (160.18) | (84.40) | (5.78) | (42.85) | (44.60) | (14.79) | (38.64) |
Altman Z″-Score (non-manufacturers) |
(138.91) | (113.73) | — | (379.16) | (253.01) | (22.99) | (119.73) | (110.04) | (35.86) | (107.50) |
P/FCF ratio |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(65.21) | (74.56) | — | (31.32) | 6,779.83 | (10.83) | (21.72) | (9.17) | (10.00) | (25.98) |
Beneish M-Score |
— | (5.21) | — | — | — | — | 1.90 | (7.82) | 182.83 | (8.74) |
P/B ratio |
4.38 | 179.74 | — | 0.00 | 0.00 | 2.99 | 38.78 | 20.36 | 2.92 | 9.62 |
Price to Tangible BV |
0.00 | 0.00 | — | 0.00 | 0.00 | 3.01 | 40.96 | 21.30 | 5.49 | 21.23 |
EV/Sales |
511.79 | 6,591.12 | — | 583.77 | 5,182.36 | 102.05 | 30.40 | 14.35 | 10.53 | 18.32 |
EV/EBITDA |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(25.41) | (42.40) | — | (5.98) | (85.11) | (2.83) | (4.10) | (1.87) | (2.24) | (3.42) |
EV/FCF |
(3.54) | (24.01) | — | (5.26) | (70.41) | (2.69) | (3.85) | (1.79) | (2.02) | (3.14) |
Quick Ratio |
0.02 | 0.17 | 0.01 | 0.06 | 0.02 | 5.21 | 0.39 | 0.08 | 1.12 | 0.76 |
Current Ratio |
0.03 | 0.21 | 0.04 | 0.17 | 0.10 | 5.76 | 0.98 | 0.74 | 1.30 | 1.35 |
Net Debt/EBITDA |
(0.03) | 0.03 | (0.02) | (0.26) | (0.12) | 1.22 | 0.03 | 0.01 | 0.05 | 0.05 |
Debt/Assets |
22.84% | 12.32% | 15.14% | 74.28% | 28.14% | 0.37% | 9.83% | 0.42% | 0.06% | 0.00% |
Debt/Equity |
0.53 | 1.41 | (0.12) | (0.37) | (0.26) | 0.00 | 0.33 | 0.02 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.19 | 0.35 | 0.18 | 0.18 |
Operating CF/Net income |
0.01 | 0.25 | 0.15 | 0.24 | 0.22 | 0.83 | 0.78 | 0.68 | 0.63 | 0.56 |
Capex/Depreciation |
(0.05) | (0.08) | (0.14) | (0.11) | (0.61) | (2.81) | (3.71) | (2.44) | (1.23) | 0.00 |
Interest Coverage |
(86.95) | (30.88) | (54.97) | (62.61) | (8.57) | 510.76 | 552.75 | (1,634.05) | (22.41) | (8.50) |
| (193.78%) | (488.82%) | 1,343.63% | 221.45% | 364.45% | (197.06%) | (259.77%) | (1,552.84%) | (343.02%) | (339.61%) | |
| (167.13%) | (134.92%) | (421.25%) | (343.23%) | (518.94%) | (121.39%) | (176.71%) | (394.48%) | (134.88%) | (168.43%) | |
ROIC |
(834.44%) | (1,545.79%) | 0.00% | 0.00% | 0.00% | 0.00% | (1,115.10%) | (1,085.05%) | (130.88%) | (306.41%) |
Return on Tangible Assets |
1,489.69% | 209.29% | 329.74% | 247.70% | 337.50% | (85.10%) | (1,450.03%) | (2,429.11%) | (407.79%) | (1,167.72%) |
Average Days of Receivables |
10.28 | 48.67 | 0.00 | 5,373.61 | 0.00 | 8.21 | 34.50 | 7.05 | 1,437.63 | 224.06 |
Research and Development Expense of Revenue |
2,364.79% | 7,926.67% | 0.00% | 352.78% | 779.37% | 410.81% | 108.63% | 144.05% | 139.81% | 123.95% |
Selling, General and Administrative Expense of Revenue |
228,576.06% | 144,526.67% | 0.00% | 55,202.78% | 14,782.54% | 3,889.36% | 919.45% | 1,041.90% | 659.36% | 648.45% |
Intangible Assets out of Total Assets |
0.98 | 0.80 | 0.85 | 0.11 | 0.03 | 0.01 | 0.02 | 0.01 | 0.21 | 0.34 |
Share Based Compensation of Revenue |
25,870.42% | 36,806.67% | 0.00% | 23,972.22% | 7,888.10% | 680.80% | 159.49% | 229.73% | 129.54% | 164.67% |
Graham Net Nets |
(0.29) | (0.05) | — | (0.52) | (0.02) | 0.30 | (0.01) | (0.10) | 0.04 | 0.02 |
Graham Number |
0.00 | 0.00 | — | 1.31 | 1.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(445.52%) | (9.52%) | — | (80.10%) | (5.61%) | (30.39%) | (30.91%) | (79.00%) | (70.00%) | (54.29%) |
Free Cash Flow Yield |
(28.59%) | (4.14%) | — | (21.76%) | (1.42%) | (24.51%) | (25.78%) | (55.53%) | (48.06%) | (31.53%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 | 0.07 | 0.06 | 0.04 |
Operating CF per Share |
(0.07) | (0.15) | (0.16) | (0.09) | (0.12) | (0.48) | (0.66) | (0.53) | (0.26) | (0.20) |
Capex per Share |
(0.02) | (0.01) | (0.02) | (0.01) | (0.03) | (0.02) | (0.04) | (0.02) | (0.03) | 0.00 |
Free Cash Flow per Share |
(0.09) | (0.16) | (0.18) | (0.11) | (0.15) | (0.50) | (0.71) | (0.55) | (0.29) | (0.20) |
Cash per Share |
0.01 | 0.06 | 0.00 | 0.00 | 0.00 | 0.70 | 0.05 | 0.01 | 0.02 | 0.01 |
Shareholders Equity per Share |
0.41 | 0.04 | (0.18) | (0.20) | (0.14) | 0.68 | 0.07 | 0.05 | 0.21 | 0.07 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.41 | 0.04 | (0.18) | (0.20) | (0.14) | 0.68 | 0.07 | 0.05 | 0.21 | 0.07 |
Free Cash Flow |
(0.18) | (0.63) | (0.84) | (0.56) | (0.93) | (4.36) | (7.22) | (7.73) | (5.89) | (6.11) |
Working Capital |
(1.04) | (1.14) | (1.48) | (0.95) | (1.26) | 5.58 | (0.03) | (0.37) | 1.29 | 0.48 |
Capital Expenditures |
(0.04) | (0.05) | (0.11) | (0.06) | (0.16) | (0.18) | (0.42) | (0.31) | (0.56) | 0.00 |
Net Current Asset Value |
(1.04) | (1.14) | (1.48) | (1.36) | (1.58) | 5.31 | (0.29) | (1.39) | 0.49 | 0.48 |
EV/EBIT |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
5.14 | 35.13 | 0.00 | 17.69 | 12.71 | 1.58 | 0.46 | 0.32 | 0.50 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1,875.50 | 34.59 | 20.13 | 5.38 | 1.22 | 0.21 | 0.18 | 0.15 | 0.60 | 3.30 |
Cash ROIC |
(14.04%) | (110.74%) | 114.79% | 88.13% | 145.27% | (35.96%) | (501.24%) | (982.55%) | (127.88%) | (239.60%) |
Accounts Receivable Turnover |
10.14 | 7.50 | 0.00 | 0.13 | 0.00 | 4.16 | 20.54 | 18.38 | 0.51 | 0.44 |
Accounts Payable Turnover |
0.87 | 0.91 | 0.10 | 0.02 | 0.02 | 0.55 | 0.48 | 0.14 | 0.17 | 0.57 |
Inventory Turnover |
0.00 | 33.77 | 4.09 | 0.00 | 0.00 | 3.63 | 0.94 | 0.27 | 0.39 | 0.90 |
Average Days of Payables |
314.71 | 435.69 | 4,006.10 | 14,713.02 | 13,948.46 | 586.68 | 972.29 | 2,944.38 | 2,176.48 | 516.42 |
Days of Inventory on Hand |
0.00 | 14.52 | 58.57 | 0.00 | 0.00 | 178.33 | 611.58 | 1,398.69 | 857.50 | 507.92 |
Average Receivables |
0.00 | 0.00 | 0.00 | 0.03 | — | 0.03 | 0.04 | 0.05 | 2.24 | 2.58 |
Average Payables |
0.85 | 0.71 | 0.81 | 0.82 | 0.60 | 0.37 | 0.46 | 0.70 | 0.82 | 0.68 |
Average Inventory |
— | 0.02 | 0.02 | — | — | 0.06 | 0.23 | 0.38 | 0.36 | 0.43 |
Average Assets |
9.29 | 1.73 | 1.13 | 0.61 | 0.68 | 4.13 | 4.93 | 2.78 | 6.23 | 6.46 |
Average Common Equity |
8.02 | 0.48 | (0.35) | (0.94) | (0.97) | 2.54 | 3.36 | 0.71 | 2.45 | 3.20 |
Columns are period end dates